Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

The enzyme 17β-HSD type 2 mainly performs oxidation in human sebaceous glands, which may help protect against acne.

Sweat gland stem cells help maintain glands, aid wound healing, and can regenerate skin structures.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Human sweat glands contain stem cells capable of self-renewal and forming different cell types.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Hormones control reproduction and are crucial for body balance.

Female hair loss patients more likely to have dry eye and gland issues.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

No definitive link between finasteride and male breast cancer, but further research is needed.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Endoscopic-assisted surgery leads to higher patient satisfaction in breast reconstruction.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.